EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Safety and Efficacy of Corneal Cross-Linking in Patients Affected by Keratoconus: Long-Term Results

Karl Anders Knutsson iD, Paola Noemi Genovese, Giorgio Paganoni, Oriella Ambrosio, Giulio Ferrari iD, Arianna Zennato, Michela Caccia, Madeleine Cataldo, Paolo Rama

Medical Sciences · 2023

DOI: 10.3390/medsci11020043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, 2023. Verfasst von Karl Anders Knutsson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cornea and Ocular Surface Unit, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy. Hauptthemen laut MEDLINE: Keratoconus, Photochemotherapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study evaluated the effectiveness and safety of corneal collagen cross-linking (CXL). A total of 886 eyes with progressive keratoconus were enrolled in a retrospective cohort study in a tertiary care university hospital. CXL was performed using a standard epithelium-off Dresden protocol. Visual outcomes, maximum keratometry (Kmax), demarcation line measurements, and complications were recorded. Visual outcomes and keratometric data were analyzed in a subgroup comprising 610 eyes. Uncorrected distance visual acuity (UDVA) improved from 0.49 ± 0.38 LogMAR to 0.47 ± 0.39 LogMAR (p = 0.03, n = 610) three years after the procedure, while corrected distance visual acuity (CDVA) improved from 0.15 ± 0.14 LogMAR to 0.14 ± 0.15 LogMAR (p = 0.007, n = 610). A significant reduction of Kmax from 56.28 ± 6.10 to 54.98 ± 6.19 (p < 0.001, n = 610) was observed three years after CXL. In five eyes (0.82%, 5/610) keratoconus progression continued after CXL. Three eyes were retreated successfully with documented refractive and topographic stability after five years. In the 35 eyes that completed 10 years of follow-up, mean visual acuity and topographic parameters remained stable. In conclusion, CXL is a safe and effective treatment for avoiding keratoconus progression. Long-term data are encouraging, supporting a high safety profile for this procedure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeratoconusPhotochemotherapyHumansCorneal Cross-LinkingPhotosensitizing AgentsRetrospective StudiesUltraviolet RaysRiboflavinCorneal TopographyFollow-Up StudiesCollagenCross-Linking Reagents

Stichwörter der Autor:innen

corneal collagen cross-linkingcorneal ectasiakeratoconus

Substanzen

Photosensitizing AgentsRiboflavinCollagenCross-Linking Reagents

Autor:innen und Institutionen

  • Cornea and Ocular Surface Unit, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy.

ORCID-Profile: Karl Anders Knutsson, Giulio Ferrari

Zitieren

APA

Knutsson, K. A., Genovese, P. N., Paganoni, G., Ambrosio, O., Ferrari, G., Zennato, A., Caccia, M., Cataldo, M., & Rama, P. (2023). Safety and Efficacy of Corneal Cross-Linking in Patients Affected by Keratoconus: Long-Term Results. Medical Sciences. https://doi.org/10.3390/medsci11020043

Vancouver

Knutsson KA, Genovese PN, Paganoni G, Ambrosio O, Ferrari G, Zennato A, et al. Safety and Efficacy of Corneal Cross-Linking in Patients Affected by Keratoconus: Long-Term Results. Medical Sciences. 2023. doi:10.3390/medsci11020043

BibTeX
@article{Knutsson2023,
  author = {Knutsson, Karl Anders and Genovese, Paola Noemi and Paganoni, Giorgio and Ambrosio, Oriella and Ferrari, Giulio and Zennato, Arianna and Caccia, Michela and Cataldo, Madeleine and Rama, Paolo},
  title = {Safety and Efficacy of Corneal Cross-Linking in Patients Affected by Keratoconus: Long-Term Results},
  journal = {Medical Sciences},
  year = {2023},
  doi = {10.3390/medsci11020043}
}
Kostenlos starten →